Abstract:Following the publication of this article, a concerned reader drew to the Editor's attention that, for the Transwell migration assay experiments shown in Fig. 5B on p. 70, an unexpected area of similarity was identified in terms of the cellular data comparing the 'Control' and 'Inhibitor + si‐SCOS5' data panels, where the results from differently performed experiments were intended to have been shown, although the areas immediately surrounding this area featured comparatively different distributions of cells. In addition, the western blots in this article were presented with atypical, unusually shaped and possibly anomalous protein bands in many cases. After having conducted an internal investigation, the Editor of Oncology Letters has reached the conclusion that the potentially anomalous data in this paper were unlikely to have arisen by coincidence. Therefore, on the grounds of a lack of confidence in the integrity of these data, the Editor has decided that the article should be retracted from the publication. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused, and thanks the concerned reader for drawing this matter to our attention. [Oncology Letters 16: 65‐72, 2018; DOI: 10.3892/ol.2018.8645]

[Retracted] Serum miR‐338‐5p has potential for use as a tumor marker for retinoblastoma

[Retracted] miR‐17‐5p promotes the growth of osteosarcoma in a BRCC2‐dependent mechanism

[Retracted] MicroRNA‐329‐3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer

[Retracted] Clinical significance of miR‐1298 in cervical cancer and its biological function in vitro

[Retracted] MicroRNA‐425 is downregulated in nasopharyngeal carcinoma and regulates tumor cell viability and invasion by targeting hepatoma‐derived growth factor

[Retracted] MicroRNA‐320 targets mitogen‐activated protein kinase 1 to inhibit cell proliferation and invasion in epithelial ovarian cancer

[Retracted] MicroRNA‐19b promotes the migration and invasion of ovarian cancer cells by inhibiting the PTEN/AKT signaling pathway

[Retracted] miR‐34a is downregulated in human osteosarcoma stem‐like cells and promotes invasion, tumorigenic ability and self‐renewal capacity

[Retracted] microRNA‐206 overexpression inhibits cellular proliferation and invasion of estrogen receptor α‐positive ovarian cancer cells

[Retracted] AdipoR1‐mediated miR‐3908 inhibits glioblastoma tumorigenicity through downregulation of STAT2 associated with the AMPK/SIRT1 pathway

[Retracted] Tissue‐specific transplantation antigen P35B functions as an oncogene and is regulated by microRNA‐125a‐5p in lung cancer

[Retracted] miR‐133b induces chemoresistance of osteosarcoma cells to cisplatin treatment by promoting cell death, migration and invasion

[Retracted] SOX2 knockdown inhibits the migration and invasion of basal cell carcinoma cells by targeting the SRPK1‐mediated PI3K/AKT signaling pathway

[Retracted] lncRNA ROR promotes the progression of renal cell carcinoma through the miR‐206/VEGF axis

[Retracted] MicroRNA‐34a expression affects breast cancer invasion in vitro and patient survival via downregulation of E2F1 and E2F3 expression

[Retracted] Effects of Grb2‐associated binding protein 2‐specific siRNA on the migration and invasion of MG‐63 osteosarcoma cells

The Potential Tumor Promotional Role of circVAPA in Retinoblastoma via Regulating miR-615-3p and SMARCE1

[Retracted] miR‐885‐5p upregulation promotes colorectal cancer cell proliferation and migration by targeting suppressor of cytokine signaling

[Retracted] miR‐143‐5p suppresses breast cancer progression by targeting the HIF‐1α‐related GLUT1 pathway

[Retracted] Silencing of RTKN2 by siRNA suppresses proliferation, and induces G1 arrest and apoptosis in human bladder cancer cells

[Retracted] miR‐218 functions as a tumor suppressor gene in cervical cancer